Hepatectomy: Clinical Trials

4 trials for Hepatectomy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 unknown. 4 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Completed 2, Unknown 2
Phase 11Completed 1
Phase 31Completed 1

Follow Hepatectomy: new trials by email Literature Review of Hepatectomy trials Research Report on Hepatectomy

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Topical rhThrombin as an Adjunct to Hemostasis During Segmental Hepatectomy
rhThrombin ( Topical ), placebo - Hepatectomy
Phase 1 / Phase 2CompletedSuzhou Zelgen Biopharmaceuticals Co.,Ltd842017-11-292021-04-14
RFA or Surgical Resection Combined With Neo-MASCT for Primary HCC: a Phase II Trial
Neo-MASCT - Primary Liver Cancer, Radiofrequency Ablation
Phase 2UnknownSun Yat-sen University982017-07-252022-01-26
The Effects of Dexamethasone Administration on Jaundice Following Liver Resection
Dexamethasone - Liver Dysfunction, Hepatectomy
Phase 2 / Phase 3CompletedShanghai Zhongshan Hospital762016-06-012021-06-10
Use of Transcollation Device to Decrease Blood Loss During Hepatic Resections: a Randomized Cohort Study (HEPACOLL)
standard bipolar coagulation, Aquamantys® probe for liver hemostasis - Hepatectomy
Phase 2UnknownUniversity Hospital, Clermont-Ferrand1402013-06-012016-07-29

Narrower conditions

Carcinoma, Hepatocellular (1)  ·  Hemorrhage (1)  ·  Hyperbilirubinemia (1)  ·  Jaundice (1)  ·  Liver Diseases (1)  ·  Thrombosis (1)

Broader conditions

Digestive System Diseases (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Adenocarcinoma (1)  ·  Carcinoma (1)  ·  Cardiovascular Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Embolism and Thrombosis (1)  ·  Liver Diseases (1)  ·  Liver Neoplasms (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Signs and Symptoms (1)

Interventions

Dexamethasone (1)  ·  dexamethasone 21-phosphate (1)  ·  recombinant human thrombin (1)

Sponsors

Shanghai Zhongshan Hospital (1)  ·  Sun Yat-sen University (1)  ·  Suzhou Zelgen Biopharmaceuticals Co.,Ltd (1)  ·  University Hospital, Clermont-Ferrand (1)

Countries

China (3)  ·  France (1)

Top investigators

Hui-Chuan Sun, MD (1)  ·  Ming Kuang, Ph.D. (1)  ·  Zhiwei Li, PhD (1)

Results publications

PMID 11231856, PMID 20940288, PMID 24224656, PMID 26176387, PMID 35476700